Reconciling incongruous qualitative and quantitative findings in mixed methods research: exemplars from research with drug using populations
- PMID: 21680168
- PMCID: PMC3210875
- DOI: 10.1016/j.drugpo.2011.05.009
Reconciling incongruous qualitative and quantitative findings in mixed methods research: exemplars from research with drug using populations
Abstract
Mixed methods research is increasingly being promoted in the health sciences as a way to gain more comprehensive understandings of how social processes and individual behaviours shape human health. Mixed methods research most commonly combines qualitative and quantitative data collection and analysis strategies. Often, integrating findings from multiple methods is assumed to confirm or validate the findings from one method with the findings from another, seeking convergence or agreement between methods. Cases in which findings from different methods are congruous are generally thought of as ideal, whilst conflicting findings may, at first glance, appear problematic. However, the latter situation provides the opportunity for a process through which apparently discordant results are reconciled, potentially leading to new emergent understandings of complex social phenomena. This paper presents three case studies drawn from the authors' research on HIV risk amongst injection drug users in which mixed methods studies yielded apparently discrepant results. We use these case studies (involving injection drug users [IDUs] using a Needle/Syringe Exchange Program in Los Angeles, CA, USA; IDUs seeking to purchase needle/syringes at pharmacies in Tijuana, Mexico; and young street-based IDUs in San Francisco, CA, USA) to identify challenges associated with integrating findings from mixed methods projects, summarize lessons learned, and make recommendations for how to more successfully anticipate and manage the integration of findings. Despite the challenges inherent in reconciling apparently conflicting findings from qualitative and quantitative approaches, in keeping with others who have argued in favour of integrating mixed methods findings, we contend that such an undertaking has the potential to yield benefits that emerge only through the struggle to reconcile discrepant results and may provide a sum that is greater than the individual qualitative and quantitative parts.
Copyright © 2011 Elsevier B.V. All rights reserved.
Similar articles
-
Evaluating the impact of Mexico's drug policy reforms on people who inject drugs in Tijuana, B.C., Mexico, and San Diego, CA, United States: a binational mixed methods research agenda.Harm Reduct J. 2014 Feb 12;11:4. doi: 10.1186/1477-7517-11-4. Harm Reduct J. 2014. PMID: 24520885 Free PMC article.
-
A comparison of syringe disposal practices among injection drug users in a city with versus a city without needle and syringe programs.Drug Alcohol Depend. 2012 Jun 1;123(1-3):255-9. doi: 10.1016/j.drugalcdep.2011.12.001. Epub 2011 Dec 29. Drug Alcohol Depend. 2012. PMID: 22209091 Free PMC article.
-
The impact of legalizing syringe exchange programs on arrests among injection drug users in California.J Urban Health. 2007 May;84(3):423-35. doi: 10.1007/s11524-006-9139-1. J Urban Health. 2007. PMID: 17265133 Free PMC article.
-
HCV infection prevalence lower than expected among 18-40-year-old injection drug users in San Diego, CA.J Urban Health. 2013 Jun;90(3):516-28. doi: 10.1007/s11524-012-9728-0. J Urban Health. 2013. PMID: 22766605 Free PMC article.
-
Syringe exchange: HIV prevention, key findings, and future directions.Int J Addict. 1995;30(12):1647-83. doi: 10.3109/10826089509104419. Int J Addict. 1995. PMID: 8557411 Review.
Cited by
-
Transforming healthcare by prioritizing qualitative and quantitative clinical trial evidence: evaluating the Aging, Community and Health Research Unit's Community Partnership Program for Older Adults (ACHRU-CPP).Trials. 2025 May 13;26(1):154. doi: 10.1186/s13063-025-08839-1. Trials. 2025. PMID: 40361198 Free PMC article. Clinical Trial.
-
A mixed methods feasibility study to evaluate the use of a low-intensity, nurse-delivered cognitive behavioural therapy for the treatment of irritable bowel syndrome.BMJ Open. 2014 Jun 17;4(6):e005262. doi: 10.1136/bmjopen-2014-005262. BMJ Open. 2014. PMID: 24939813 Free PMC article. Clinical Trial.
-
Correlates and contexts of US injection drug initiation among undocumented Mexican migrant men who were deported from the United States.AIDS Behav. 2012 Aug;16(6):1670-80. doi: 10.1007/s10461-011-0111-z. AIDS Behav. 2012. PMID: 22246511 Free PMC article.
-
Interdisciplinary mixed methods research with structurally vulnerable populations: case studies of injection drug users in San Francisco.Int J Drug Policy. 2013 Mar;24(2):101-9. doi: 10.1016/j.drugpo.2012.12.004. Epub 2013 Jan 9. Int J Drug Policy. 2013. PMID: 23312109 Free PMC article.
-
Creating safe spaces to prevent unintentional childhood injuries among the Bedouins in southern Israel: A hybrid model comprising positive deviance, community-based participatory research, and entertainment-education.PLoS One. 2021 Sep 22;16(9):e0257696. doi: 10.1371/journal.pone.0257696. eCollection 2021. PLoS One. 2021. PMID: 34551005 Free PMC article.
References
-
- Agar M. Recasting the “Ethno” in “Epidemiology”. Medical Anthropology. 1997;16:391–403. - PubMed
-
- Bazeley P. Integrating Data Analyses in Mixed Methods Research. Journal of Mixed Methods Research. 2009;3(3):203–207.
-
- Bluthenthal RN, Kral AH, Lorvick J, Watters JK. Impact of Law Enforcement on Syringe Exchange Programs: A Look at Oakland and San Francisco. Medical Anthropology. 1997;18(1):61–83. - PubMed
-
- Bourgois P. Anthropology and Epidemiology on Drugs: The Challenges of Cross-Methodological and Theoretical Dialogue. International Journal of Drug Policy. 2002;13:259–269.
Publication types
MeSH terms
Grants and funding
- 1R36DA024968/DA/NIDA NIH HHS/United States
- R01 DA019829/DA/NIDA NIH HHS/United States
- K01 DA022923/DA/NIDA NIH HHS/United States
- R01 DA016017/DA/NIDA NIH HHS/United States
- K01 DA031031/DA/NIDA NIH HHS/United States
- R01DA019829/DA/NIDA NIH HHS/United States
- R37 DA019829/DA/NIDA NIH HHS/United States
- R36 DA024968/DA/NIDA NIH HHS/United States
- T32 DA023356/DA/NIDA NIH HHS/United States
- T32DA023356/DA/NIDA NIH HHS/United States
- R01 DA031056/DA/NIDA NIH HHS/United States
- K01DA022923/DA/NIDA NIH HHS/United States
- K01DA031031/DA/NIDA NIH HHS/United States
- 2R01DA016017-07/DA/NIDA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical